 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 321
|
|
-
Novosom granted US and European patents for RNAi-delivering Smarticles
(16 May 2008)
Novosom AG announced that it has been granted patents for both the USA and Europe for its Drug Delivery technology Smarticles®. Smarticles® are fully charge reversible liposomes for the in vivo drug delivery of nucleotides like siRNA or ......
-
QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes
(15 May 2008)
Joint development and collaboration enables enhanced production of every human protein, spurring advances in drug development
QIAGEN and GENEART announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins. According to the company, QIAgenes is the world's first comprehensive set of ......
-
Affimed validates antibody target for cancer metastasis
(14 May 2008)
Affimed Therapeutics AG announced that a collaboration with Dr. Stefan Weiss at the Institute of Biochemistry of the Ludwig Maximilian University in Munich has strongly validated a target for cancer metastases amenable to the development of ......
-
KeyNeurotek Pharmaceuticals Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist
(13 May 2008)
KeyNeurotek Pharmaceuticals AG announced positive results of a Phase I study with its cannabinoid receptor-agonist KN38-7271. KN38-7271 is being developed for the treatment of patients suffering from acute neurodegenerative incidents like a ......
-
CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
(09 May 2008)
CRELUX and ProQinase announced that they have entered into a joint agreement to supply customers with crystal-grade protein kinases and readily available kinase complex structures. Under the agreement, CRELUX and ProQinase will establish and ......
-
An award for young scientists in a young discipline
(08 May 2008)
Systems Biology is a young field. It has the potential to fundamentally change the life sciences and generate radically new insights for biomedical research as well as for industry and agriculture. Its overall aim is to better understand life ......
-
DIREVO announces validation of bestMab
(08 May 2008)
New approach for the optimization of therapeutic antibodies generates optiMIRA, an enhanced version of Adalimumab (Humira)
DIREVO Biotech AG announced that it has validated its "bestMab(TM)" platform through the generation of an optimized version of the anti-inflammatory antibody, Adalimumab (Humira®), with unprecedentedly strong binding properties. optiMIRA(TM) ......
-
QIAGEN and BioHelix Enter Into Licensing Agreement
(05 May 2008)
Helicase-dependent isothermal DNA amplification system provides new assay technology capabilities for QIAGEN's assay automation platforms
QIAGEN and privately held BioHelix have announced that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's proprietary Helicase Dependent Amplification technology (HDA). HDA is a versatile assay ......
-
ProBioGen and Boehringer Ingelheim enter into Strategic Production Alliance
(02 May 2008)
ProBioGen AG announced a strategic production agreement with Boehringer Ingelheim. Under the agreement, ProBioGen will integrate some of Boehringer Ingelheim´s technologies to accommodate a seamless process and technology transfer from pilot ......
-
Roche Diagnostics Licenses the Technology used for the LightCycler System to BIOTECON
(02 May 2008)
Roche Diagnostics and BIOTECON Diagnostics GmbH have entered into a licensing agreement concerning Roche's LightCycler system technology. Under the terms of the agreement, Roche grants a non-exclusive worldwide license to BIOTECON authorizing ......
|
|
|
Top